Human cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to- mesenchymal transition

PLoS Pathogens

Volumn 6, Issue 11, 2010, Pages

  Shimamura, Masako ^a   Murphy Ullrich, Joanne E ^b   Britt, William J ^a,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR; GELATINASE A; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IN VITRO STUDY; KIDNEY ALLOGRAFT; KIDNEY TUBULE CELL; OPEN READING FRAME; PROTEIN EXPRESSION; VIRUS GENE; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; CYTOMEGALOVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOPRECIPITATION; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOGENICITY; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIROLOGY; WESTERN BLOTTING;

HUMAN HERPESVIRUS 5; RATTUS;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; KIDNEY TUBULES, PROXIMAL; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79251469381     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001170     Document Type: Article

References (69)

1. Rubin RH, Tolkoff-Rubin NE, Oliver D, Rota TR, Hamilton J, et al. (1985) Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 40: 243-249.
2. Schnitzler MA, Woodward RS, Brennan DC, Spitznagel EL, Dunagan WC, et al. (1997b) The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation. American Journal of Kidney Diseases 29: 428-434.
3. Schnitzler MA, Woodward RS, Brennan DC, Spitznagel EL, Dunagan WC, et al. (1997a) Impact of cytomegalovirus serology on graft survival in living related kidney transplantation: implications for donor selection. Surgery 121: 563-568.
4. Gerstenkorn C, Balupuri S, Mohamed MA, Manas DM, Ali S, et al. (2000a) The impact of cytomegalovirus serology for 7-year graft survival in cadaveric kidney transplantation-the Newcastle experience. Transplant International 13: S372-374.
5. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, et al. (2004) Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney International 66: 329-337.
6. Koskinen PK, Yilmaz S, Kallio E, Bruggeman CA, Hayry PJ, et al. (1996) Rat cytomegalovirus infection and chronic kidney allograft rejection. Transplant International 9: S3-4.
7. Lautenschlager I, Soots A, Krogerus L, Kauppinen H, Saarinen O, et al. (1997) CMV increases inflammation and accelerates chronic rejection in rat kidney allografts. Transplantation Proceedings 29: 802-803.
8. van Dam JG, Li F, Yin M, You XM, Grauls G, et al. (2000) Effects of cytomegalovirus infection and prolonged cold ischemia on chronic rejection of rat renal allografts. Transplant International 13: 54-63.
9. Cohen AH, Nast CC (1998) TGF-b in Renal Allograft Rejection. Mineral and Electrolyte Metabolism 24: 197-201.
10. Suthanthiran M, Strom TB (1998) Mechanisms and management of acute renal allograft rejection. Surg Clin North Am 78: 77-94.
11. Campistol JM, Inigo P, Larios S, Bescos M, Oppenheimer F (2001) Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. Nephrology Dialysis Transplantation 1: 114-116.
12. Robertson H, Keong Wong W, Talbot D, Burt AD, Kirby JA (2001) Tubulitis after renal transplantation: Demonstration of an association between CD103+ T cells, transforming growth factor-b1 expression and rejection grade. Transplantation January 27 71: 306-313.
13. Ozdemir BH, Ozdemir FN, Demirhan B, Haberal M (2005) TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity. Transplantation 80: 1681-1685.
14. Pankewycz OG, Miao L, Isaacs R, Guan J, Pruett T, et al. (1996) Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney International 50: 1634-1640.
15. Helantera I, Loginov R, Koskinen P, Tornroth T, Gronhagen-Riska C, et al. (2005) Persistent cytomegalovirus infection is associated with increased expression of TGF-b1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts. Nephrology Dialysis Transplantation 20: 790-796.
16. Lautenschlager I, Soots A, Krogerus L, Inkinen K, Kloover J, et al. (1999) Timerelated effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model. Intervirology 42: 279-284.
17. Inkinen K, Holma K, Soots A, Krogerus L, Loginov R, et al. (2003) Expression of TGF-beta and PDGF-AA antigens and corresponding mRNAs in cytomegalovirus-infected rat kidney allografts. Transplantation Proceedings 35: 804-805.
18. Stahl PJ, Felsen D (2001) Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. American Journal of Pathology 159: 1187-1192.
19. Bottinger EP, Bitzer M (2002) TGF-beta signaling in renal disease. Journal of the American Society of Nephrology 13: 2600-2610.
20. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, et al. (2002) Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney International 62: 137-146.
21. Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292.
22. Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. Journal of the American Society of Nephrology 15: 1-12.
23. Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, et al. (2002) Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. Journal of Clinical Investigation 110: 1525-1538.
24. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, et al. (2003) BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nature Medicine 9: 964-968.
25. Michelson S, Alcami J, Kim SJ, Danielpour D, Bachelerie F, et al. (1994) Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1. Journal of Virology 68: 5730-5737.
26. Kossmann T, Morganti-Kossmann MC, Orenstein JM, Britt WJ, Wahl SM, et al. (2003) Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-beta release. Journal of Infectious Diseases 187: 534-541.
27. Kwon YJ, Kim DJ, Kim JH, Park CG, Cha CY, et al. (2004) Human cytomegalovirus (HCMV) infection in osteosarcoma cell line suppresses GMCSF production by induction of TGF-beta. Microbiology & Immunology 48: 195-199.
28. Yoo YD, Chiou CJ, Choi KS, Yi Y, Michelson S, et al. (1996) The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site. Journal of Virology 70: 7062-7070.
29. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J (2001) Latency, activation, and binding proteins of TGF-beta. Microscopy Research & Technique 52: 354-362.
30. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. Journal of Cell Science 116: 217-224.
31. Tabata T, Kawakatsu H, Maidji E, Sakai T, Sakai K, et al. (2008) Induction of an Epithelial Integrin {alpha}v{beta}6 in Human Cytomegalovirus-Infected Endothelial Cells Leads to Activation of Transforming Growth Factor-{beta}1 and Increased Collagen Production. Am J Pathol 172: 1127-1140.
32. Ulrich W, Schlederer MP, Buxbaum P, Stummvoll H, Rockenschaub S, et al. (1986) The histopathologi identification of CMV infected cells in biopsies of human renal allografts. An evaluation of 100 transplant biopsies by in situ hybridization. Pathology, Research & Practice 181: 739-745.
33. Hendrix RM, Wagenaar M, Slobbe RL, Bruggeman CA (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. Journal of Clinical Pathology 50: 59-63.
34. Holma K, Tornroth T, Gronhagen-Riska C, Lautenschlager I (2000) Expression of the cytomegalovirus genome in kidney allografts during active and latent infection. Transplant International 13: S363-S365.
35. Markovic-Lipkovski J, Muller CA, Engler-Blum G, Strutz F, Kuhn W, et al. (1992) Human cytomegalovirus in rejected kidney grafts; detection by polymerase chain reaction. Nephrology Dialysis Transplantation 7: 865-870.
36. Gerstenkorn C, Robertson H, Mohamed MA, O'Donnell M, Ali S, et al. (2000b) Detection of cytomegalovirus (CMV) antigens in kidney biopsies and transplant nephrectomies as a marker for renal graft dysfunction. Clinical Chemistry & Laboratory Medicine 38: 1201-1203.
37. Alcami J, Paya C, Virelizier J, Michelson S (1993) Antagonistic modulation of human cytomegalovirus replication by transforming growth factor beta and basic fibroblastic growth factor. J Gen Virol 74: 269-274.
38. Massague J (2000) How cells read TGF-beta signals. Nature Reviews Molecular Cell Biology 1: 169-178.
39. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB (1988) Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. Journal of Biological Chemistry 263: 7741-7746.
40. Wang D, Shenk T (2005) Human Cytomegalovirus UL131 Open Reading Frame Is Required for Epithelial Cell Tropism. J Virol 79: 10330-10338.
41. Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, et al. (2004) Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. Journal of Biological Chemistry 279: 8592-8601.
42. Helantera I, Teppo A-M, Koskinen P, Tornroth T, Gronhagen-Riska C, et al. (2006) Increased urinary excretion of transforming growth factor-[beta]1 in renal transplant recipients during cytomegalovirus infection. Transplant Immunology 15: 217-221.
43. Zeisberg M, Maeshima Y, Mosterman B, Kalluri R (2002) Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. American Journal of Pathology 160: 2001-2008.
44. Catania JM, Chen G, Parrish AR (2007) Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292: F905-F911.
45. Rodrigo E, Lopez-Hoyos M, Escallada R, Fernandez-Fresnedo G, Ruiz JC, et al. (2000) Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrology Dialysis Transplantation 15: 2041-2045.
46. Nicholson ML, Waller JR, Bicknell GR (2002) Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA. British Journal of Surgery 89: 933-937.
47. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, et al. (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. Journal of Biological Chemistry 275: 12080-12089.
48. Bernardo MM, Fridman R (2003) TIMP-2 (tissue inhibitor of metalloproteinase- 2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochemical Journal 374: 739-745.
49. Tian Y-C, Chen Y-C, Chang C-T, Hung C-C, Wu M-S, et al. (2007) Epidermal growth factor and transforming growth factor-[beta]1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Experimental Cell Research 313: 2367-2377.
50. Streblow DN, Kreklywich CN, Andoh T, Moses AV, Dumortier J, et al. (2008) The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant 8: 277-287.
51. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annual Review of Cell & Developmental Biology 17: 463-516.
52. Hummel M, Zhang Z, Yan S, DePlaen I, Golia P, et al. (2001) Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. Journal of Virology 75: 4814-4822.
53. Zhang Z, Li Z, Yan S, Wang X, Abecassis M (2009) TNF-alpha signaling is not required for in vivo transcriptional reactivation of latent murine cytomegalovirus. Transplantation 88: 640-645.
54. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, et al. (1994) An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Analytical Biochemistry 216: 276-284.
55. Britt WJ, Auger D (1986) Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus. Journal of Virology 58: 185-191.
56. Cassady KA (2005) Human Cytomegalovirus TRS1 and IRS1 Gene Products Block the Double-Stranded-RNA-Activated Host Protein Shutoff Response Induced by Herpes Simplex Virus Type 1 Infection. J Virol 79: 8707-8715.
57. Boppana SB, Smith RJ, Stagno S, Britt WJ (1992) Evaluation of a microtiter plate fluorescent-antibody assay for rapid detection of human cytomegalovirus infection. J Clin Microbiol 30: 721-723.
58. Balcarek KB, Warren W, Smith RJ, Lyon MD, Pass RF (1993) Neonatal screening for congenital cytomegalovirus infection by detection of virus in saliva. J Infect Dis 167: 1433-1436.
59. Shimamura M, Mach M, Britt WJ (2006) Human cytomegalovirus infection elicits a glycoprotein M (gM)/gN-specific virus-neutralizing antibody response. J Virol 80: 4591-4600.
60. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499.
61. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB (1990) Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. Journal of Cell Biology 111: 757-763.
62. Galardy RE, Cassabonne ME, Giese C, Gilbert JH, Lapierre F, et al. (1994) Low molecular weight inhibitors in corneal ulceration. Ann N Y Acad Sci 732: 315-323.
63. Huang X, Wu J, Spong S, Sheppard D (1998) The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci 111(Pt 15): 2189-2195.
64. Zhou Y, Hagood JS, Murphy-Ullrich JE (2004) Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. American Journal of Pathology 165: 659-669.
65. Todor DR, Lewis I, Bruno G, Chyatte D (1998) Identification of a Serum Gelatinase Associated With the Occurrence of Cerebral Aneurysms as Pro- Matrix Metalloproteinase-2. Stroke 29: 1580-1583.
66. Smith IL, Cherrington JM, Jiles RE, Fuller MD, Freeman WR, et al. (1997) High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis 176: 69-77.
67. Smith IL, Taskintuna I, Rahhal FM, Powell HC, Ai E, et al. (1998) Clinical Failure of CMV Retinitis With Intravitreal Cidofovir Is Associated With Antiviral Resistance. Arch Ophthalmol 116: 178-185.
68. Williams-Aziz SL, Hartline CB, Harden EA, Daily SL, Prichard MN, et al.(2005) Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro. Antimicrob Agents Chemother 49: 3724-3733.
69. Bradford Russell D, Cloud G, Lakeman Alfred D, Boppana S, Kimberlin David W, et al. (2005) Detection of Cytomegalovirus (CMV) DNA by Polymerase Chain Reaction Is Associated with Hearing Loss in Newborns with Symptomatic Congenital CMV Infection Involving the Central Nervous System. The Journal of Infectious Diseases 191: 227-233.